TY - JOUR
T1 - Profiling of Extracellular Small RNAs Highlights a Strong Bias towards Non-Vesicular Secretion
AU - Sork, Helena
AU - Conceicao, Mariana
AU - Corso, Giulia
AU - Nordin, Joel
AU - Lee, Yi Xin Fiona
AU - Krjutskov, Kaarel
AU - Orzechowski Westholm, Jakub
AU - Vader, Pieter
AU - Pauwels, Marie
AU - Vandenbroucke, Roosmarijn E.
AU - Wood, Matthew Ja
AU - El Andaloussi, Samir
AU - Mäger, Imre
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/6/18
Y1 - 2021/6/18
N2 - The extracellular environment consists of a plethora of molecules, including extracellular miRNA that can be secreted in association with extracellular vesicles (EVs) or soluble protein complexes (non-EVs). Yet, interest in therapeutic short RNA carriers lies mainly in EVs, the vehicles conveying the great majority of the biological activity. Here, by overexpressing miRNA and shRNA sequences in parent cells and using size exclusion liquid chromatography (SEC) to separate the secretome into EV and non-EV fractions, we saw that >98% of overexpressed miRNA was secreted within the non-EV fraction. Furthermore, small RNA sequencing studies of native miRNA transcripts revealed that although the abundance of miRNAs in EVs, non-EVs and parent cells correlated well (R2 = 0.69-0.87), quantitatively an outstanding 96.2-99.9% of total miRNA was secreted in the non-EV fraction. Nevertheless, though EVs contained only a fraction of secreted miRNAs, these molecules were stable at 37 °C in a serum-containing environment, indicating that if sufficient miRNA loading is achieved, EVs can remain delivery-competent for a prolonged period of time. This study suggests that the passive endogenous EV loading strategy might be a relatively wasteful way of loading miRNA to EVs, and active miRNA loading approaches are needed for developing advanced EV miRNA therapies in the future.
AB - The extracellular environment consists of a plethora of molecules, including extracellular miRNA that can be secreted in association with extracellular vesicles (EVs) or soluble protein complexes (non-EVs). Yet, interest in therapeutic short RNA carriers lies mainly in EVs, the vehicles conveying the great majority of the biological activity. Here, by overexpressing miRNA and shRNA sequences in parent cells and using size exclusion liquid chromatography (SEC) to separate the secretome into EV and non-EV fractions, we saw that >98% of overexpressed miRNA was secreted within the non-EV fraction. Furthermore, small RNA sequencing studies of native miRNA transcripts revealed that although the abundance of miRNAs in EVs, non-EVs and parent cells correlated well (R2 = 0.69-0.87), quantitatively an outstanding 96.2-99.9% of total miRNA was secreted in the non-EV fraction. Nevertheless, though EVs contained only a fraction of secreted miRNAs, these molecules were stable at 37 °C in a serum-containing environment, indicating that if sufficient miRNA loading is achieved, EVs can remain delivery-competent for a prolonged period of time. This study suggests that the passive endogenous EV loading strategy might be a relatively wasteful way of loading miRNA to EVs, and active miRNA loading approaches are needed for developing advanced EV miRNA therapies in the future.
KW - SEC
KW - extracellular RNA
KW - extracellular vesicles
KW - miRNA
KW - small RNA
UR - http://www.scopus.com/inward/record.url?scp=85110378085&partnerID=8YFLogxK
U2 - 10.3390/cells10061543
DO - 10.3390/cells10061543
M3 - Article
C2 - 34207405
AN - SCOPUS:85110378085
SN - 2073-4409
VL - 10
SP - 1
EP - 17
JO - Cells
JF - Cells
IS - 6
M1 - 1543
ER -